

Roll over image to zoom in
Resof Total (EPCLUSA) Sofosbuvir/Velpatasvir online
$239.00
Status: In stock
A fixed-dose combination tablet of sofosbuvir 400 mg and velpatasvir 100 mg used to treat chronic hepatitis C (genotypes 1 to 6) in adults. It covers patients without cirrhosis and those with compensated cirrhosis, and is combined with ribavirin for decompensated cirrhosis.
Resof Total, also known as âEPCLUSAÂź, Sofosvel, MyHep All, Hepcvel, VelasofïŒVelpaclear, SoviHep Vâ is a fixed dose combination medication for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1, 2, 3, 4, 5, or 6 infections without cirrhosis or with compensated cirrhosis and in combination with ribavirin for those with decompensated cirrhosis. It combines Sofosbuvir 400mg and velpatasvir 100mg. It is more than 90% effective for hepatitis C. Sofosbuvir 400mg/Velpatasvir 100 mgâs brand name is EPCLUSAÂź by Gilead. Resof Total is a generic Hepatitis C prescription medicine from Dr Reddyâs, which is one of the biggest pharmaceutical company in India.
Â
Â













